title: Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes.
authors.forename: Gianni
authors.initials: G
authors.lastname: Gerlini
authors.forename: Paola
authors.initials: P
authors.lastname: Di Gennaro
authors.forename: Giulia
authors.initials: G
authors.lastname: Mariotti
authors.forename: Carmelo
authors.initials: C
authors.lastname: Urso
authors.forename: Alberto
authors.initials: A
authors.lastname: Chiarugi
authors.forename: Nicola
authors.initials: N
authors.lastname: Pimpinelli
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Borgognoni
mesh_terms: D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism*; D037181:Lectins, C-Type / Q000378:metabolism*; D008198:Lymph Nodes / Q000276:immunology / Q000473:pathology; D008545:Melanoma / Q000276:immunology / Q000473:pathology*; D008562:Membrane Glycoproteins / Q000378:metabolism*; D011971:Receptors, Immunologic / Q000378:metabolism*; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology*
chemical_list: C443299:CLEC4C protein, human; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D037181:Lectins, C-Type; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic